Preclinical development of T cell receptor gene therapy
- 1 April 2009
- journal article
- review article
- Published by Elsevier in Current Opinion in Immunology
- Vol. 21 (2) , 209-214
- https://doi.org/10.1016/j.coi.2009.02.007
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Control of HIV-1 immune escape by CD8 T cells expressing enhanced T-cell receptorNature Medicine, 2008
- Insertional oncogenesis in 4 patients after retrovirus-mediated gene therapy of SCID-X1Journal of Clinical Investigation, 2008
- Loss of T cell-mediated antitumor immunity after construct-specific downregulation of retrovirally encoded T-cell receptor expression in vivoCancer Gene Therapy, 2008
- A safeguard eliminates T cell receptor gene-modified autoreactive T cells after adoptive transferProceedings of the National Academy of Sciences, 2008
- Enhanced Antitumor Activity of T Cells Engineered to Express T-Cell Receptors with a Second Disulfide BondCancer Research, 2007
- Facilitating matched pairing and expression of TCR chains introduced into human T cellsBlood, 2006
- Cancer Regression in Patients After Transfer of Genetically Engineered LymphocytesScience, 2006
- Enhanced Antitumor Activity of Murine-Human Hybrid T-Cell Receptor (TCR) in Human Lymphocytes Is Associated with Improved Pairing and TCR/CD3 StabilityCancer Research, 2006
- αβ T-Cell Receptor Engineered γδ T Cells Mediate Effective Antileukemic ReactivityCancer Research, 2006
- Transgenic TCR expression: comparison of single chain with full-length receptor constructs for T-cell functionCancer Gene Therapy, 2004